⌘K
Loading ticker…
Harrow, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Harrow, Inc. Common Stock (HROW) has a 3-month relative strength percentile of 70 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.5%, relative volume 1.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
70 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
HROW is in a stage 1 base, week 3. Currently in a 119-day base; basing ADR 5.2% (broad 5.7%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 13.2% / 1.9%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
HROW is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $35M notional. Top 3 carry $75M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $35M |
| IWMiShares Russell 2000 ETF | 0.04% | $27M |
| VXFVanguard Extended Market ETF | 0.02% | $13M |
| IWOiShares Russell 2000 Growth ETF | 0.07% | $9M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.83% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HROW Jan avg: -9.51% median: -11.67% win: 25% σ: 8.28% n: 4 2022-04-12 → 2026-05-29 | HROW Feb avg: 14.16% median: 16.45% win: 75% σ: 17.08% n: 4 2022-04-12 → 2026-05-29 | HROW Mar avg: 0.03% median: 6.40% win: 50% σ: 26.25% n: 4 2022-04-12 → 2026-05-29 | HROW Apr avg: 0.69% median: -0.88% win: 40% σ: 17.08% n: 5 2022-04-12 → 2026-05-29 | HROW May avg: 11.61% median: 6.79% win: 60% σ: 39.25% n: 5 2022-04-12 → 2026-05-29 | HROW Jun avg: 6.67% median: 4.80% win: 100% σ: 7.45% n: 4 2022-04-12 → 2026-05-29 (current) | HROW Jul avg: 8.92% median: 9.98% win: 75% σ: 13.66% n: 4 2022-04-12 → 2026-05-29 | HROW Aug avg: 20.56% median: 28.29% win: 75% σ: 37.38% n: 4 2022-04-12 → 2026-05-29 | HROW Sep avg: 15.91% median: 17.33% win: 75% σ: 17.00% n: 4 2022-04-12 → 2026-05-29 | HROW Oct avg: -5.49% median: -0.29% win: 25% σ: 10.75% n: 4 2022-04-12 → 2026-05-29 | HROW Nov avg: -9.83% median: -7.15% win: 25% σ: 19.12% n: 4 2022-04-12 → 2026-05-29 | HROW Dec avg: 12.76% median: 19.31% win: 75% σ: 22.72% n: 4 2022-04-12 → 2026-05-29 |